Arnott, I D R <br/><br/>
An analysis of factors influencing short-term and sustained response to infliximab treatment for Crohn's disease.  [electronic resource] 

 -  Alimentary pharmacology & therapeutics  Jun 2003 
 - 1451-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0269-2813 
<br/><br/><label>Standard No.: </label>10.1046/j.1365-2036.2003.01574.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antibodies, Monoclonal--therapeutic use<br/>Chronic Disease<br/>Crohn Disease--drug therapy<br/>Female<br/>Gastrointestinal Agents--therapeutic use<br/>Humans<br/>Infliximab<br/>Infusions, Intravenous<br/>Intestinal Fistula--etiology<br/>Long-Term Care<br/>Male<br/>Survival Analysis<br/>Treatment Outcome